Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on Verona Pharma (VRNA)
-
Zscaler (ZS) PT Raised to $340 at Cantor Fitzgerald
-
Cabaletta Bio (CABA) Announces Proposed Share Offering
-
Cabaletta Bio Announces Proposed Public Offering of Securities
-
Orchid Island Capital Announces June 2025 Monthly Dividend and May 31, 2025 RMBS Portfolio Characteristics
-
Rocket Lab USA (RKLB) PT Raised to $35 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Joby Aviation Inc (JOBY)
-
Cantor Fitzgerald Reiterates Overweight Rating on Eve Holding Inc. (EVEX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Archer Aviation Inc. (ACHR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Varonis Systems (VRNS)
-
Cantor Fitzgerald Reiterates Overweight Rating on VinFast Auto Ltd. (VFS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Merck (MRK)
-
Cantor Fitzgerald Reiterates Overweight Rating on Vaxcyte (PCVX)
-
Cantor Fitzgerald Reiterates Neutral Rating on Pfizer (PFE)
-
Cantor Fitzgerald Reiterates Overweight Rating on Cidara Therapeutics (CDTX)
-
Form N-CSR CANTOR FITZGERALD INFRAS For: Mar 31
-
Exro Technologies Provides Corporate Update
-
AMD (AMD) PT Raised to $140 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Oracle (ORCL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Snowflake Inc. (SNOW)
-
Cantor Fitzgerald Reiterates Overweight Rating on MongoDB (MDB)
-
Robinhood Markets (HOOD) PT Raised to $89 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Nano-X Imaging (NNOX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Cantor Fitzgerald Starts Docebo Inc. (DCBO) at Overweight
-
Cantor Fitzgerald Starts eToro Group (ETOR) at Overweight
-
Form 8-K Cantor Fitzgerald Income For: Jun 06
-
Phathom Pharmaceuticals (PHAT) PT Raised to $29 at Cantor Fitzgerald
-
Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Cantor Fitzgerald: BIO CEO says US Needs a Biomanufacturing Renaissance
-
Cipher Mining (CIFR) PT Raised to $6 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Planet Labs (PL)
-
MongoDB (MDB) PT Raised to $271 at Cantor Fitzgerald
-
Point and Funds Managed by Blue Owl Capital Close Oversubscribed $248 Million Home Equity Investment Rated Securitization
-
Cantor Fitzgerald Assumes GH Research PLC (GHRS) at Overweight, ' Smoking the Toad - A Big Wave of Psychedelics Is Coming'
-
Aveanna Healthcare Holdings Completes Acquisition of Thrive Skilled Pediatric Care
-
Cantor Fitzgerald Reiterates Overweight Rating on CrowdStrike Holdings (CRWD)
-
Cantor Fitzgerald Reiterates Neutral Rating on Humana (HUM)
-
Cantor Fitzgerald Reiterates Overweight Rating on UnitedHealth Group (UNH)
-
Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Centene (CNC)
-
Cantor Fitzgerald Reiterates Neutral Rating on Shopify (SHOP)
-
Cantor Fitzgerald Reiterates Neutral Rating on Alphabet (GOOGL)
-
Etsy (ETSY) PT Raised to $52 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts NewAmsterdam Pharma Co NV (NAMS) at Overweight
-
Trevi Therapeutics (TRVI) Offering 17.4M Shares at $5.75
-
Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on Kura Oncology (KURA)

